Skip to main content
NCBI home page
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Pediatr Res. 2011 Feb;69(2):112–117. doi: 10.1203/PDR.0b013e318204dcb8

Nitrotyrosine Impairs Angiogenesis and Uncouples eNOS Activity of Pulmonary Artery Endothelial Cells Isolated from Developing Sheep Lungs

Ru-Jeng Teng 1, Tzong-Jin Wu 1, C Gaston Bisig 1, Annie Eis 1, Kirkwood A Pritchard 1, Girija G Konduri 1
PMCID: PMC3086583  NIHMSID: NIHMS279443  PMID: 21057377

Abstract

Infection is known to impair the growth of developing lungs. It is known that plasma free nitrotyrosine (NT) levels can reach 150 μM during sepsis. Free NT incorporates into microtubules and impairs cell function. We hypothesize that free NT perturbs the angiogenic activity of pulmonary artery endothelial cells (PAEC) in developing lungs. PAEC from fetal lamb lungs were incubated with NT (1-100 μM). We examined the effects of NT on tube formation, cell proliferation, apoptosis and α-tubulin assembly in PAEC. We assessed superoxide anion (O2-) and nitric oxide (NO) levels in PAEC during NT exposure. Effects of NT on endothelial NO synthase (eNOS) were examined with respect to eNOS-dimer formation and the association of eNOS chaperone, heat-shock-protein-90 (hsp90). NT decreased tube formation and increased apoptosis in PAEC. NT also decreased NO levels, increased NOS- dependent O2- generation and promoted α-tubulin depolymerization. Although NT increased eNOS homodimer formation, it decreased the hsp90 association with eNOS. Our data suggest that increased NT formation during sepsis may uncouple eNOS activity and increase oxidative stress. Since NO plays an important role in angiogenesis and vasodilation, these observations suggest a mechanism for the impaired vasodilation and angiogenesis during sepsis in the developing lung.

Introduction

Infection is known to affect the growth of developing lungs, especially in premature infants. Premature infants are at an increased risk of bronchopulmonary dysplasia (BPD) which is characterized by impaired alveolar formation and decreased blood vessel density in the lungs (1). Previous studies have pointed out a significant association between postnatal infection and the development of BPD (2). It is known that during sepsis, increased levels of superoxide (O2-) and nitric oxide (NO) increase the formation of peroxynitrite (3), which nitrates tyrosine to form 3-nitrotyrosine (NT). NT can also be formed via NO2, H2O2 with nitrite, or myeloperoxidase-mediated processes during infection (4).

In healthy subjects, plasma concentrations of free NT are generally less than 1 μM (5). During severe sepsis, free NT levels can increase to 1-150 μM (6). Originally, NT was considered to be merely a footprint for increased nitrosative stress. However, emerging evidence suggests that NT is more than an innocent biomarker. Free NT impairs vascular endothelial function (7), impairs the response of systemic arteries to angiotensin II (8) and inhibits the proliferation of vascular smooth muscle cells (9). Free NT also can be incorporated into α-tubulin, via tubulin-tyrosine ligase, to impair cytoskeleton function (10). Whether this incorporation is a reversible or irreversible process remains unclear.

The cytoskeleton plays vital roles in cell proliferation, migration/invasion, and apoptosis, all of which are involved in the process of angiogenesis. Microtubule assembly can modulate hsp90 and calmodulin, two proteins that are required for coupled endothelial nitric oxide synthase (eNOS) activity (11). Chemical reagents that alter the cytoskeleton are used to kill tumors by either inducing cell apoptosis (12) or inhibiting angiogenesis (13). NT can potentially impair the growth of developing lungs by inhibition of angiogenesis. However, the effects of NT on angiogenesis in developing lungs have not been explored previously. Here we hypothesize that [1] free NT incorporates into microtubules of pulmonary artery endothelial cells (PAEC); [2] the incorporation of free NT impairs angiogenesis of PAEC isolated from developing lungs; and [3] free NT uncouples eNOS activity to reduce NO bioavailability. The studies were done in PAEC isolated from fetal lamb lungs delivered prematurely by cesarean section.

Materials and Methods

The use of animals for isolation of PAEC was approved by the Medical College of Wisconsin Institutional Animal Care and Use Committee (IACUC) and conformed to the guidelines of the NIH for the care and use of laboratory animals. PAEC were isolated from 132-day gestation fetal lambs (Term=145 days) using methods we previously described (14). The pulmonary arteries were dissected up to the third generation branches in the lung and PAEC were isolated using 0.1% collagenase type A. Cell identity was confirmed by staining for factor VIII antigen and acetylated-LDL uptake (14).

The BrdU assay kit, cell death detection kit, and in situ cell death TUNEL-POD kit were from Roche Applied Science (Indianapolis, IN). Recombinant human vascular endothelial growth factor (VEGF) was obtained from NCIFCRF-Biological Resources Branch of National Cancer Institute and dihydroethidium (DHE) and 4-amino-5-methylamino-2′,7′-difluorofluoresceine diacetate (DAF-FM-DA) from Invitrogen (Carlsbad, CA). All other chemicals were obtained from Sigma-Aldrich (St. Louis, MO).

Monoclonal anti-α-tubulin antibodies (B-5-1-2 and D-M-1-A), horseradish peroxidase (HRP)-conjugated anti-rabbit IgG, Protein A-sepharose, and anti-mouse IgG were from Sigma. Monoclonal anti-eNOS antibodies were from BIOMOL (clone H32) and Invitrogen (clone 9D10). Monoclonal anti-hsp90 antibody (clone 68) and growth-factor-reduced Matrigel was from BD Biosciences (Bedford, MA). ExactaCruz™ E, Preclearing Matrix E, and ExactaCruz™ E-HRP were from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal NT antibodies (clone 4709) and Cu,Zn-superoxide dismutase (Cu,Zn-SOD) was provided by Dr. J.S. Beckman. Polyclonal anti-nitrotyrosinated-α-tubulin antibody was from Dr. C.A. Arce. ImageJ (NIH) software was used to analyze the band densities for Western blots.

Preparation of NT stock solution

NT from Sigma-Aldrich was freshly dissolved in sterile 0.1N NaOH and filtered through 0.22 micron filter, to make 10 mM stock solution. The pH of control media were adjusted with 0.1N NaOH (8.04±0.01 versus 8.05±0.01). After 48 hours in the incubator, there was no difference in pH between NT-containing media (7.52±0.07) and NaOH-adjusted media (7.45±0.03).

Cell cultures

PAECs were cultured in DMEM with 20% FCS in our experiments and appropriate amount of 0.1N NaOH was used to adjust the pH of the medium.

Incorporation of NT into microtubules

PAECs at ∼80% confluence were serum-starved (0.5% FCS) for 2h. The medium was renewed and incubated for 48h with different amounts of NT and appropriate amount of NaOH to adjust the pH. One plate (80 μM NT) was then changed to NT-free medium for another 24h for comparison. For immunoprecipitation the cells were exposed to NT for 48h. PAECs were lysed in RIPA buffer and treated with Preclearing Matrix E. The supernatant was incubated with anti-α-tubulin (B-5-1-2) antibody and ExactaCruz™ E. The immunoprecipitates were separated by 7.5% SDS-PAGE before transferring to nitrocellulose membranes. The membranes were blotted with polyclonal NT (1:5,000), polyclonal nitrotyrosinated-α-tubulin (1:800), or monoclonal α-tubulin antibody (D-M-1-A, 1:1,000). Goat anti-rabbit-IgG-HRP (1:10,000) served as the secondary antibody for nitrated proteins, whereas ExactaCruz™ E-HRP was used for α-tubulin. Signal was developed using enhanced chemiluminescence and autoradiography to CL-Xposure film (Pierce). Integrated optical densities (IOD) were quantified using ImageJ.

Angiogenic activities

Cell growth, apoptosis/necrosis, proliferation, and tube formation assays were performed as previously described (14).

AECs, 1×105 per well in 12-well plate, were cultured until attached and media were renewed with/without 50 μM NT. Cells were trypsinized after 48h and counts (viable and non-viable) were obtained using hemocytometer after trypan-blue exclusion stain. Similar experiments were performed with 50 μM NT after adding the scavengers of reactive oxygen species, Cu,Zn-SOD (1 μg/mL) and/or catalase (420 U/mL), and after adding NOS antagonist, Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME, 300 μM).

In situ TUNEL stain was used to detect apoptosis (15). PAECs 2×104 were cultured in 96-well plates, for apoptosis/necrosis and cell proliferation assays, to near confluence then serum-starved for 2h. The media was changed with/without 50 μM NT for overnight. Anti-histone-III antibody or bromo-deoxy-uridine (BrdU) was then added. Absorbance at 560 nm was measured after addition of the chromophore as the reflection of cell apoptosis/necrosis or proliferation, respectively (14).

Matrigel 50 μl was added to each well of 96-well plate and 2×104 of PAECs were seeded per well. Each well contained DMEM (5% FCS) and VEGF (10-9 M) with/without NT at 1, 10, or 100 μM, or no VEGF/NT (controls). Tube lengths were measured for each condition.

Levels of O2- and NO by epifluorescence

NT effect on PAEC O2- levels was examined by both reduced ferricytochrome-c assay and DHE epifluorescence whereas NO production was assessed using DAF-FM-DA epifluorescence after digitonin treatment. PAECs were incubated with NT overnight at ∼ 60% confluence. Epifluorescence expressed as integrated relative light unit (RLU) was measured by MetaVue software.

Immunofluorescent staining of microtubules

PAECs (∼60% confluence) were incubated overnight with NT before fixation in cold (-20°C) methanol. The slides were rehydrated (PBS with 0.1% saponin) for 1h, followed by blocking solution (PBS, 0.1% saponin, and 5% goat serum) for 1h. The slides were treated with primary antibody (B-5-1-2; 1:200) at 4°C overnight, washed and incubated with FITC-conjugated anti-mouse antibody (1:320). Pictures were taken using fluorescence microscope (Ex490/Em520).

eNOS homodimer formation and hsp90 association

Homodimer formation was evaluated using low-temperature immunoblots (16). PAEC were incubated overnight in media with or without NT (100 μM) at ∼80% confluence followed by lysis in RIPA buffer. Lysates were immunoprecipitated with monoclonal anti-eNOS antibody (H32). Proteins were separated by 7.5% SDS-PAGE. Monoclonal anti-eNOS antibody (9D10, 1:500) and monoclonal anti-hsp90 antibody (1:500) were used to identify the protein signals on the nitrocellulose membrane. HRP-conjugated anti-mouse IgG antibody was used (1:9,000) as the secondary antibody and exposed to CL-Xposure film after treatment with enhanced chemiluminescence. IOD of the bands were analyzed using ImageJ and IOD ratios of signals for hsp90 and corresponding eNOS were calculated for comparison.

Statistical analysis

Data were expressed as mean ± S.E. One-way ANOVA followed by Student-Newman-Keuls test was used for comparisons among more than two groups. Student t-test, or Mann-Whitney test, was used for comparing two groups wherever appropriate. A p-value <0.05 was considered statistically significant.

Results

NT incorporates into microtubules

Immunoblots using polyclonal NT antibody showed several nitrated protein bands in cell lysates from both control and NT-treated PAEC cultures. A prominent nitrated protein band (∼50Kd) was observed only in the lysates from NT-treated PAEC (Figure 1A). This nitrated protein band corresponds to α-tubulin and the signal increased with exposure to increasing concentrations of NT. Replacing the culture media with NT-deficient media decreased the signal of nitrated protein band (Figure 1B) suggesting that incorporation of NT is either a reversible process or that NT is enzymatically degraded. Immunoprecipitation of α-tubulin showed that α-tubulin was nitrated in direct relation to NT concentrations (Figure 1C) and the nitrotyrosinated α-tubulin was seen only in NT treated cells. An anti-nitrotyrosinated-α-tubulin antibody detects NT that has been incorporated into the c-terminus of α-tubulin (Figure 1D) (17).

Figure 1.

Figure 1

Open in a new tab

NT incorporates into α-tubulin. One nitrated band (∼50 Kd) was seen only in NT treated PAEC (A). Immunoblot of NT treated PAECs showed similar signals of α-tubulin but a nitrated band with similar molecular weight as α-tubulin that disappeared after changing back to NT-free medium for 24 hours (B). Immunoprecipitation using anti-α-tubulin antibody showed a dose-dependent increase in signals of nitrated α-tubulin (C). A protein band (∼50Kd) was seen in NT treated PAEC but not in control, using anti-nitrotyrosinated-α-tubulin antibody, indicating that NT incorporated into the c-terminus of the α-tubulin (D). C= control; N= NT; 80 μM-R= NT at 80 μM for 48h and then recovered in NT-free media for another 24h.

NT reduces the cell growth, decreases cell proliferation, and increases cell death

NT decreased the number of proliferating PAEC. Addition of Cu,Zn-SOD to NT-treated cultures caused further decreases in PAEC number. Catalase alone had no effect on cell counts when PAEC were incubated with NT. Addition of both catalase and Cu,Zn-SOD to NT-treated PAEC cultures increased cell counts to control levels (Figure 2A). The difference in cell counts was mainly due to difference in viable cells (Figure 2B). These results suggest that both O2- and H2O2 impair PAEC proliferation,whereas scavenging both radicals by the combination of Cu,Zn-SOD and catalase is protective. Addition of L-NAME to NT treated PAEC blocked the inhibitory effects of NT on cell counts (Figure 2C). L-NAME also tempered the Cu,Zn-SOD effect on cell counts (Figure 2D). These data suggest that NOS-dependent O2- contributes to the inhibition of PAEC proliferation by NT.

Figure 2.

Figure 2

Open in a new tab

Cell growth, apoptosis/necrosis and proliferation of PAEC are affected by NT. (A) The presence of SOD+CAT gave similar cell counts as controls, whereas with SOD alone the cell counts decreased further (*= p<0.01 versus control; ‡= p<0.01 versus NT; †= p<0.01 versus both control and NT+SOD). (B) In the absence of NT, both CAT alone and SOD alone decreased viable cell counts (□) whereas CAT+SOD gave similar counts as control (*= p<0.05 compared to control and SOD+CAT). No difference in non-viable cell counts was seen (■); (C) Both NT alone and L-NAME alone decreased viable cell counts (□) whereas NT+L-NAME gave similar counts as control (*= p<0.05 compared to control and NT+L-NAME). No difference in non-viable cell counts was seen (■). (D) L-NAME ameliorates the cell count lowering effect by the combination of Cu,Zn-SOD and NT. (E) In situ TUNEL stain showed fewer apoptotic nuclei (white arrow) in controls than (F) in 1 μM NT. (G) There was a dose-response relationship between the percentages of apoptosis and concentrations of NT (*= p < 0.05 versus control; =p<0.05 versus 10 μM; ‡= p < 0.05 versus NT 1 μM; †= p< 0.05 versus NT 100 μM). (H) Apoptosis/necrosis assay showed an increased index (■), whereas the BrdU assay showed decreased proliferation with NT (□, *= p < 0.05 versus control).

Control PAECs had low levels of apoptosis (Figure 2E). NT increased apoptosis by nearly 2.6-fold (Figure 2F). Apoptosis increased to 17.4±2.4%, 22.4±1.9%, and 28.3±1.2% as the concentration of NT increased to 1, 10, and 100 μM, respectively (p<0.001, Figure 2G). Analysis using anti-histone-III antibody showed that 50 μM NT increased the index of apoptosis/necrosis from 13.9 ± 4.0 % to 26.2 ± 4.4% (p=0.022). Finally, NT 50 μM decreased cell proliferation assessed by BrdU incorporation (0.149 ± 0.004 vs. 0.136 ± 0.002, Figure 2H).

NT decreases tube formation

VEGF increased tube formation by control PAEC at 6h (223.6±13.3% vs. 100.0±12.4%, p<0.01) but not at 14h (94.8±16.3% vs. 127.9±7.7%, p=0.10). NT decreased VEGF induced tube formation. At 6h, the total tube lengths were 77.3±8.%, 68.1±3.6%, and 57.0±6.9% for 1, 10, and 100 μM NT, respectively (p<0.001). These differences persisted even at 14h (65.4±8.7%, 50.4±7.3%, and 39.0±6.1% for 1, 10, and 100 μM NT, respectively, p<0.001, Figure 3F) Branching points per high-power-field were 3.2±0.6 for un-stimulated PAEC at 6h and increased to 7.8±0.4 in the presence of VEGF but no difference was seen at 14h (2.4±0.7 versus 2.2±0.2). NT decreased the branch point number to 2.2±0.4 and 1.2±0.4 at 1 μM, 1.6±0.2 and 0.4±0.2 at 10 μM, and 1.6±0.4 and 0.6±0.2 at 100 μM for 6h and 14h respectively.

Figure 3.

Figure 3

Open in a new tab

NT inhibits VEGF-enhanced angiogenesis in PAEC. Total tube lengths for control (A) increased in the presence of VEGF (B) whereas the presence of 1 μM (C), 10 μM (D) and 100 μM (E) NT impaired the VEGF-enhanced tube formation. Similar findings are seen at both 6 and 14 hours (F, □=6h and ■=14 h). *= p<0.001for VEGF tube formation at 6h compared to other treatments; **= p<0.001 for NT at both 6h and 14h compared to VEGF alone.

NT affects polymerization of microtubules

Immunofluorescent staining for α-tubulin showed filamentous microtubules in PAEC (Figure 4A). The filamentous structures surrounding the perinuclear area disappeared when PAEC were incubated with 1 μM NT (Figure 4B) and 10 μM NT (Figure 4C). The more diffuse the staining, the more the microtubules are de-polymerized. In the presence of 100 μM NT, PAEC appeared to be smaller with a diffuse speckled pattern (Figure 4D). These images suggest that free NT increases microtubule depolymerization (18).

Figure 4.

Figure 4

Open in a new tab

NT promotes depolymerization of the microtubules. Immunofluorescent staining showed well organized microtubules in PAEC (A) but the filamentous structures around the perinuclear region disappeared with 1 μM NT (B) and became more diffuse at 10 μM NT (C). In the presence of 100 μM NT the cells became smaller in size and with some speckled staining for the microtubules (D, 200×).

NT affects eNOS homodimer formation and hsp90 association

NT increased eNOS homodimer formation (Figure 5A) but decreased eNOS association with hsp90 (∼50%) even after stimulation with eNOS agonist, ATP (Figure 5B). Since hsp90 is a required cofactor for NO synthesis, it appears that free NT uncouples eNOS by decreasing hsp90 association rather than by increasing eNOS monomer formation.

Figure 5.

Figure 5

Open in a new tab

NT increases eNOS dimerization (A) but decreases eNOS-hsp90 association (B). * = p<0.05 versus control; ‡ = p<0.05 versus control.

NT affects the levels of O2- and NO

NT increased both basal and ATP-stimulated DHE epifluorescence. L-NAME decreased the NT enhanced DHE epifluorescence (Figure 6A), suggesting that NOS is the source of increased epifluorescence. Inhibition of DHE epifluorescence by SOD suggests that the increased epifluorescence with NT is due to O2- (Figure 6B). Similarly, using ferricytochrome-C reduction assay, PAEC cultures that were incubated with NT had increased basal O2- levels (Figure 6C).

Figure 6.

Figure 6

Open in a new tab

NT increases O2- levels by PAEC. NT increased the L-NAME inhibitable (A) and Cu, Zn-SOD inhibitable (B) DHE epifluorescence by PAEC both without (□) or with (■) ATP (10-5 M) stimulation. Similar results were seen also by reduced ferricytochrome-C assay (C). C= control; A= ATP; N= NT; NA= NT+ATP. *= p<0.05 versus control; †= p<0.05 versus NT without ATP stimulation; ‡= p<0.05 versus NT with ATP stimulation.

NT decreased the DAF-FM-DA epifluorescence, both at basal level and in response to ATP stimulation (Figure 7). L-NAME decreased DAF-FM-DA epifluorescence in the presence/absence of NT, suggesting that DAF-FM-DA fluorescence was due to NO. Taken together, these results suggest that NT uncouples eNOS activity to increases eNOS dependent O2- production.

Figure 7.

Figure 7

Open in a new tab

NT decreases NO levels by PAEC. NT treatment decreased L-NAME inhibitable DAF-FM-DA epifluorescence by PAEC (A). NT decreases DAF-FM-DA epifluorescence by PAEC both without and with ATP (10-5M) stimulation (B). †=p<0.05 compared to control without ATP stimulation (□); *= p<0.05 compared to control with ATP stimulation (■). C= control; A= ATP; N= NT; NA= NT+ATP.

Discussion

PAEC from prematurely delivered fetal lambs, readily incorporate free NT into α-tubulin. This leads to microtubule depolymerization, decreased cell size and impaired angiogenesis by PAEC. Our data also suggest that eNOS uncoupling is associated with impaired angiogenesis by NT. Using two different assays for the detection of O2-, we observed that NT increases O2- production in PAEC by a NOS-dependent mechanism (19). We also observed a decrease in hsp90-eNOS association after incubation with NT suggesting a mechanism for NT induced eNOS uncoupling. These findings demonstrate that NT is more than a simple biomarker of oxidative stress and may contribute to the impaired angiogenesis observed in premature infants with infections.

The effect of NT on pulmonary vascular endothelial function, especially during the developmental stage, has not been studied before. Using PAEC from fetal lambs allows us to examine the potential effects of NT on the angiogenesis function in developing lungs. In this study we used NT in a range of concentrations (1-100 μM) that are seen during infection (6). We observed marked protein nitration in cell lysates that corresponds to α-tubulin after NT treatment. Immunoblots using antibody that was specifically raised against nitrotyrosinated-α-tubulin verified that NT was incorporated into α-tubulin as previously described (17). Removal of NT from the media for 24h dramatically decreases the levels of nitrated α-tubulin in PAEC as reported earlier by Bisig et al (17). Although the specific mechanisms for scavenging nitrated proteins in PAEC remain unknown, these data suggest that the effects of NT on PAEC function may be reversible. Since nitrotyrosinated-α-tubulin is resistant to carboxypeptidase (10), it is possible that other enzyme systems are involved in the removal of NT or denitration of NT. We can not rule out the possible role of normal protein turnover in the process.

Nosocomial infections develop in 20% of very low birth weight infants (20). Infection contributes to lung injury and increases the risk of BPD in premature infants (21). Increased formation of O2- during infection decreases NO availability and also generates peroxynitrite, a potent nitrating agent through the reaction between NO and O2-. Protein nitration can affect cell function (22) and NT inhibits tumor growth (23). A potential mechanism for the alteration of cell function by NT is the post-translational nitrotyrosination of α-tubulin (10). Microtubules play critical roles in maintaining cell structure, intracellular transport, and mitosis. Previous studies demonstrated that a reversible, posttranslational modification of tyrosine residue occurs at the c-terminus of the α-tubulin (24). Dynamic microtubules, characteristic of dividing cells, have tyrosine incorporated into their c-terminus (tyrosinated), whereas stable, long-lived microtubules have their tyrosine removed from the c-terminus (detyrosinated). Drugs targeting the cytoskeleton have been studied extensively as antitumor agents, and some of their effects were attributed to inhibition of angiogenesis (25). Since α-tubulin plays a vital role in the formation of microtubules, it is possible that modification of α-tubulin can affect cell function and differentiation (7-9,26).

Free NT is excreted through kidneys but impaired kidney function is commonly seen in septic premature neonates which can lead to high plasma levels of NT. Since cell proliferation and angiogenesis are very active in the developing lungs, higher NT concentration may have a potential detrimental effect on lung development. The relationship between NT concentration in the media and signal density of nitrotyrosinated-α-tubulin observed in our study is similar to previous reports (9,10). However, unlike previous studies (10), we observed that NT incorporation into α-tubulin is a reversible process in fetal PAECs.

Microtubule-active agents are known to modify NO production (18) and cell migration in vascular endothelial cells (27). Using nocodazole, Su et al. observed that disruption of microtubules leads to decreased NO production and hsp90- eNOS association. Our findings suggest that NT also disrupts polymerized microtubules and leads to eNOS uncoupling. We also found that NT reduces cell proliferation, as reported in other cell lines (9). Our observation that scavenging both O2- and H2O2 improves cell counts suggests that the effect of NT is mediated by ROS. Several oxidative enzymes in PAECs can be a source of O2- (28). L-NAME improved the cell counts after NT treatment, suggesting that eNOS uncoupling after NT incorporation to α-tubulin contributes to the increased O2- production.

We previously demonstrated that disrupting the interaction between hsp90 and eNOS leads to eNOS uncoupling (19). In this study we found that NT increases eNOS homodimer formation but decreases hsp90-eNOS association. With increased O2- production and decreased NO production, we believe that NT uncouples eNOS by blocking the interaction between hsp90 and eNOS. It is also possible that the increased O2- reacted with NO to form peroxynitrite and nitrated the tyrosine(s) of α-tubulin (29) which may also contribute to NT formation in our samples. It is also possible that eNOS or hsp90, is nitrated and leads to eNOS uncoupling. The later possibility deserves further investigation.

In conclusion, increased free NT which occurs during infection, may result in altered endothelial cell biology and impaired angiogenesis. This is especially important to the developing lungs since impaired angiogenesis can affect alveolar growth and lung development (1). The limitation of our study is that we did not test our hypothesis in intact animals. Since kidneys effectively excrete free NT, it is difficult to study the in vivo effect of NT unless kidney function is impaired in the study animals. However, investigation of angiogenesis using cultured PAEC provides an excellent model system to obtain mechanistic information about the impaired angiogenesis. Can our findings be one of the explanations why inhalational NO therapy fails to show benefit in decreasing BPD in very premature infants remains to be determined. Future studies will address the long-term effects of NT on lung growth and differentiation in vivo.

Acknowledgments

Financial Support: The study was supported by NHLBI HL-081139-04 to K.A. Pritchard, Jr., and a research grant from Advancing Healthier Foundation, NHLBI RO1-HL-057268 and CRI endowment fund to G.G. Konduri.

Abbreviations

DAF-FM-DA

4-amino-5-methylamino-2′,7′-difluorofluoresceine diacetate

DHE

dihydroethidium

eNOS

endothelial nitric oxide synthase

hsp90

heat-shock-protein-90

NT

3-nitrotyrosine

O2-

superoxide anion

PAEC

pulmonary artery endothelial cell

References

  • 1.Abman SH. Bronchopulmonary dysplasia: “a vascular hypothesis. Am J Respir Crit Care Med. 2001;164:1755–1756. doi: 10.1164/ajrccm.164.10.2109111c. [DOI] [PubMed] [Google Scholar]
  • 2.Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, Martin C. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr. 2002;140:171–176. doi: 10.1067/mpd.2002.121381. [DOI] [PubMed] [Google Scholar]
  • 3.Blough NV, Zafiriou OC. Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg Chem. 1985;24:3502–3504. [Google Scholar]
  • 4.Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 1998;391:393–397. doi: 10.1038/34923. [DOI] [PubMed] [Google Scholar]
  • 5.Frost MT, Barry Halliwell B, Moore KP. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem J. 2000;345:453–458. [PMC free article] [PubMed] [Google Scholar]
  • 6.Fukuyama N, Takebayashi Y, Hida M, Ischda H, Ichimori K, Nakazawa H. Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic Biol Med. 1997;22:771–774. doi: 10.1016/s0891-5849(96)00401-7. [DOI] [PubMed] [Google Scholar]
  • 7.Kooy NW, Lewis SJ. Nitrotyrosine attenuates the hemodynamic effects of adrenoceptor agonists in vivo: relevance to the pathophysiology of peroxynitrite. Eur J Pharmacol. 1996;310:155–161. doi: 10.1016/0014-2999(96)00376-7. [DOI] [PubMed] [Google Scholar]
  • 8.Mihm MJ, Jing L, Bauer JA. Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage. J Cardiovasc Pharmacol. 2000;36:182–187. doi: 10.1097/00005344-200008000-00007. [DOI] [PubMed] [Google Scholar]
  • 9.Phung AD, Soucek K, Kubala L, Harper RW, Bulinski JC, Eiserich JP. Posttranslational nitrotyrosination of alpha-tubulin induces cell cycle arrest and inhibits proliferation of vascular smooth muscle cells. Eur J Cell Biol. 2006;85:1241–1252. doi: 10.1016/j.ejcb.2006.05.016. [DOI] [PubMed] [Google Scholar]
  • 10.Eiserich JP, Estevez AG, Bamberg TV, Ye YZ, Chumley PH, Beckman JS, Freeman BA. Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: a nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci USA. 1999;96:6365–6370. doi: 10.1073/pnas.96.11.6365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Czar MJ, Welsh MJ, Pratt WB. Immunofluorescence localization of the 90-kDa heat-shock protein to cytoskeleton. Eur J Cell Biol. 1996;70:322–330. [PubMed] [Google Scholar]
  • 12.Wang LG, Liu XM, Kreis W, Budman DR. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol. 1999;44:355–361. doi: 10.1007/s002800050989. [DOI] [PubMed] [Google Scholar]
  • 13.Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by Docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther. 2002;1:1191–1200. [PubMed] [Google Scholar]
  • 14.Teng RJ, Eis A, Bakhutashvili I, Arul N, Konduri GG. Increased superoxide production contributes to the impaired angiogenesis of fetal pulmonary arteries with in utero pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2009;297:L184–L195. doi: 10.1152/ajplung.90455.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G. Simultaneous determination of cell surface antigens and apoptosis. Trends Genet. 1994;10:41–42. doi: 10.1016/0168-9525(94)90140-6. [DOI] [PubMed] [Google Scholar]
  • 16.Klatt P, Schmidt K, Lehner D, Glatter O, Bächinger HB, Mayer B. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. EMBO J. 1995;14:3687–3695 HB. doi: 10.1002/j.1460-2075.1995.tb00038.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bisig CG, Purro SA, Contin MA, Barra HS, Arce CA. Incoporation of 3-nitrotyrosine into the C-terminus of α-tubulin is reversible and not detrimental to dividing cells. Eur J Biochem. 2002;269:5037–5045. doi: 10.1046/j.1432-1033.2002.03220.x. [DOI] [PubMed] [Google Scholar]
  • 18.Su Y, Zharikov SI, Block ER. Microtubule-active agents modify nitric oxide production in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2002;282:L1183–L1189. doi: 10.1152/ajplung.00388.2001. [DOI] [PubMed] [Google Scholar]
  • 19.Konduri GG, Bakhutashvili I, Eis A, Pritchard K., Jr Oxidant stress from uncoupled nitric oxide synthase impairs vasodilation in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2007;292:H1812–H1820. doi: 10.1152/ajpheart.00425.2006. [DOI] [PubMed] [Google Scholar]
  • 20.Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, Fanaroff AA, Lemons JA, Donovon EF, Oh W, Stevenson DK, Ehrenkranz RA, Papile LA, Verter J, Wright LL. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 1996;129:63–71. doi: 10.1016/s0022-3476(96)70191-9. [DOI] [PubMed] [Google Scholar]
  • 21.Kallapur SG, Jobe AH. Contribution of inflammation to lung injury and development. Arch Dis Child Fetal Neonatal Ed. 2006;91:F132–F135. doi: 10.1136/adc.2004.068544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Peluffo G, Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res. 2007;75:291–302. doi: 10.1016/j.cardiores.2007.04.024. [DOI] [PubMed] [Google Scholar]
  • 23.MacLean SJ, Huber RE. The effects of DL-p-fluorophenylalanine and L-3-nitrotyrosine on the growth and biochemistry of the Taper liver tumor. Cancer Res. 1971;31:1669–1672. [PubMed] [Google Scholar]
  • 24.Barra HS, Arce CA, Argaraña CE. Post-translational tyrosination/detyrosination of tubulin. Mol Neurobiol. 1988;2:133–153. doi: 10.1007/BF02935343. [DOI] [PubMed] [Google Scholar]
  • 25.Hinnen P, Eskens FA. Vascular disrupting agents in clinical development. Br J Cancer. 2007;96:1159–1165. doi: 10.1038/sj.bjc.6603694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chang W, Webster DR, Salam AA, Gruber D, Prasad A, Eiserich JP, Bulinski JC. Alteration of the c-terminal amino acid of tubulin specifically inhibits myogenic differentiation. J Biol Chem. 2002;277:30690–30698. doi: 10.1074/jbc.M204930200. [DOI] [PubMed] [Google Scholar]
  • 27.Lu H, Murtagh J, Schwartz EL. The microtubule binding drug Laulimalide inhibits vascular endothelial growth factor-induced human endothelial cell migration and is synergistic when combined with Docetaxel (Taxotere) Mol Pharmacol. 2006;69:1207–1215. doi: 10.1124/mol.105.019075. [DOI] [PubMed] [Google Scholar]
  • 28.Li PF, Dietz R, von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation. 1997;96:3602–3609. doi: 10.1161/01.cir.96.10.3602. [DOI] [PubMed] [Google Scholar]
  • 29.Tedeschi G, Cappelletti G, Negri A, Pagliato L, Maggioni MG, Maci R, Ronchi S. Characterization of nitroproteome in neuron-like PC12 cells differentiated with nerve growth factor: Identification of two nitration sites in α-tubulin. Proteomics. 2005;5:2422–2432. doi: 10.1002/pmic.200401208. [DOI] [PubMed] [Google Scholar]

RESOURCES